Identification of gene targets against dormant phase Mycobacterium tuberculosis infections
2007
Identifying Drug Targets for Dormant Tuberculosis
publication
Evidence: moderate
Author Information
Author(s): Dennis J. Murphy, James R. Brown
Primary Institution: GlaxoSmithKline
Hypothesis
Can we identify novel drug targets for dormant Mycobacterium tuberculosis infections using gene expression data?
Conclusion
The study proposes several novel anti-TB targets that could improve current treatments for tuberculosis.
Supporting Evidence
- Current TB therapy is lengthy and complicated, leading to poor patient compliance.
- Identifying gene targets specific to the dormant phase of M. tuberculosis is crucial for developing effective treatments.
- Several promising drug targets were identified based on gene expression trends in dormant bacteria.
Takeaway
Researchers looked at genes from dormant tuberculosis bacteria to find new ways to treat the disease more effectively.
Methodology
A meta-analysis of multiple published datasets from gene expression DNA microarray experiments and genome-wide insertional mutagenesis was performed.
Limitations
The study acknowledges that no single model fully replicates the conditions of human pathogenicity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website